LungBlog

Pfizer, Inc. revealed it has received a positive opinion from the Committee for Medical Products for Human Use or CHMP to authorize the marketing of Champix, which is the company’s new drug for the treatment of smoking cessation.

Our own Dr. David Jablons made the LungBlog today.  Adding their own contributions to a rapidly advancing field, UCSF researchers – along with colleagues from Incyte Corporation and the University of Texas Southwestern Medical Center – have described new targets in lung cancer and evaluated a promising new drug candidate that halts growth signals in tumor cells grown in the lab.

Researchers from the University of Pittsburgh have created a program called Synchrony.  The new software allows for easier detection of tumors thereby raising new hope against lung cancer. It also allows CyberKnife to accurately target tumors that move as a result of breathing.

Trying to quit smoking? Experts offer?several tips to help you quit the habit.

Doctors are testing a radical new way to help smokers quit: a shot that “immunizes” them against the nicotine rush that fuels their addiction.

A lab mouse who was infected not once but twice with mesothelioma survived thanks to drugs made from compounds extracted from the fruit of devil’s apple.

Yes, it’s true.  The CyberKnife is now going to be available for treatment of lung tumours.  Read all about it here.

Tobacco smoke contains agents that cause cancer. But nicotine itself isn’t one of them. Instead, nicotine promotes the growth of existing cancer cells.

I know I posted a similar article regarding thermal ablation with radiation, but just in case you missed it… here’s another one.

A blood test may be able to detect lung cancer much earlier than the most accurate imaging systems now used, say researchers.

I’ve posted articles regarding this in the past, but it is so exciting that I couldn’t pass it up!